Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma

Abstract

Background: The transcriptome public database and advances in biological discoveries contributed to significant progresses in identifying the drivers of cancer progression. Cellular senescence (CS) is considered as a leading factor resulting in cancer development. The purpose of this study was to explore the significance of CS-related genes in the molecular classification and survival outcome of clear cell renal cell carcinoma (ccRCC).Methods: CS-related genes were obtained from the CellAge database, and patients from TCGA-KIRC dataset and ICGC dataset were clustered by ConsesusClusterPlus. The characteristics of overall survival (OS), genomic variation, and tumor microenvironment (TME) of each cluster were analyzed. Least Absolute Shrinkage and Selection Operator (LASSO) Cox regression analysis was conducted to develop a CS-related risk model to score ccRCC patients and assess the risk scores in predicting patients' response to immunotherapy and chemotherapy. A nomogram based on the risk model was established to improve the risk stratification of patients.Results: CcRCC was divided into three molecular subtypes based on CSrelated genes. The three molecular phenotypes showed different OS and clinical manifestations, mutation patterns, and TME states. Five genes were obtained from nine differentially expressed CS-related genes in the three molecular subtypes to develop a risk model. Patients with ccRCC were Frontiers in Immunology frontiersin.org 01

Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma

“…Previous studies demonstrated that ccRCC is highly infiltrated by different immune cells and has high immune heterogeneity [ 98 , [101] , [102] , [103] ]. We found that high-risk patients had more plentiful immune and stromal components, lower tumor purity in the TME, and more abundant immunosuppressive cells.…”

A senescence-associated signature refines the classification of different modification patterns and characterization of tumor immune microenvironment infiltration in triple-negative breast cancer

“…Wang et al (Wang et al, 2022) used the senescence-related gene set to define a cellular senescence score in pancancer and demonstrated that this score can represent the degree of immune activation in the tumor microenvironment and can identify groups with better prognosis. In specific cancers, researchers have also constructed classification models and prognostic prediction models based on senescence gene sets, including clear cell renal cell carcinoma (Lu et al, 2022), hepatocellular carcinoma (Luo et al, 2022), glioblastoma (Tan et al, 2022), etc., and explored the relationship between senescencerelated genes and clinical characteristics, tumor microenvironment, immunotherapy, etc. These studies demonstrate the importance of senescence genes in cancer therapy.…”

Prognosis signature for predicting the survival and immunotherapy response in esophageal carcinoma based on cellular senescence-related genes

“…By integrating these and other datasets developers performed a systems biology analysis of cell senescence. At present, there are few studies on CSRGs in ECa, but a number of studies have shown that CSRGs signature can play a prognostic role in hepatocellular carcinoma, gastric cancer, bladder cancer, renal cell carcinoma, and colon cancer (17)(18)(19)(20)(21). However, the expression characteristics and prognostic significance of CSRGs in ECa remain unclear.…”